We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
-17.84%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
AUM
$1.04B
AUM Growth
-$265M
Cap. Flow
-$35.2M
Cap. Flow %
-3.39%
Top 10 Hldgs %
25.91%
Holding
396
New
14
Increased
86
Reduced
173
Closed
104

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.36%
2 Technology 15.45%
3 Healthcare 14.57%
4 Consumer Staples 10.16%
5 Financials 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSLA icon
276
Tesla
TSLA
$1.38T
$217K 0.02%
+6,225
New +$258K
GM icon
277
General Motors
GM
$75.7B
$216K 0.02%
10,396
-13,198
-56% -$403K
XLP icon
278
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
$216K 0.02%
3,974
+387
+11% +$23.5K
IWS icon
279
iShares Russell Mid-Cap Value ETF
IWS
$15.8B
$213K 0.02%
3,319
-96
-3% -$8.21K
IYH icon
280
iShares US Healthcare ETF
IYH
$3.74B
$211K 0.02%
5,625
HBAN icon
281
Huntington Bancshares
HBAN
$34.2B
$144K 0.01%
+17,500
New +$215K
LUMN icon
282
Lumen
LUMN
$6.23B
$144K 0.01%
15,205
-749
-5% -$9.37K
OXY icon
283
Occidental Petroleum
OXY
$59.1B
$138K 0.01%
11,925
-181
-1% -$5.95K
CCL icon
284
Carnival Corporation Ltd
CCL
$33.9B
$135K 0.01%
+10,239
New +$364K
BMY.RT
285
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$107K 0.01%
28,124
+1,684
+6% +$5.55K
CMRX
286
DELISTED
Chimerix, Inc.
CMRX
$53K 0.01%
37,013
FBIO icon
287
Fortress Biotech
FBIO
$92.4M
$38K ﹤0.01%
1,333
ADMS
288
DELISTED
Adamas Pharmaceuticals
ADMS
$38K ﹤0.01%
13,000
TCON
289
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$26K ﹤0.01%
+750
New +$43.6K
BCRX icon
290
BioCryst Pharmaceuticals
BCRX
$2.51B
$22K ﹤0.01%
+11,000
New +$30.3K
ATNM icon
291
Actinium Pharmaceuticals
ATNM
$31.7M
$4K ﹤0.01%
762
AIVL icon
292
WisdomTree US AI Enhanced Value Fund
AIVL
$431M
-100
Closed -$9K
AZO icon
293
AutoZone
AZO
$48.4B
-170
Closed -$203K
BBH icon
294
VanEck Biotech ETF
BBH
$460M
-815
Closed -$114K
BLV icon
295
Vanguard Long-Term Bond ETF
BLV
$5.74B
-7
Closed -$1K
CMF icon
296
iShares California Muni Bond ETF
CMF
$4.62B
-50
Closed -$3K
CSD icon
297
Invesco S&P Spin-Off ETF
CSD
$224M
-530
Closed -$27K
DBEU icon
298
Xtrackers MSCI Europe Hedged Equity ETF
DBEU
$793M
-11,820
Closed -$368K
DD icon
299
DuPont de Nemours
DD
$18.5B
-3,044
Closed -$245K
DEM icon
300
WisdomTree Emerging Markets High Dividend Fund
DEM
$4.14B
-12
Closed -$1K

Similar funds

Dowling & Yahnke's Q1 2020 Portfolio in Review

As of Q1 2020, Dowling & Yahnke held 396 positions worth $1.04B, down 20% from $1.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Dowling & Yahnke withdrew a net $35.2M in Q1 2020, closing 104 positions and reducing 173 holdings. Its most notable exit was DocuSign, an estimated $977K position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Dowling & Yahnke opened a new position in iShares MSCI ACWI ex US ETF worth $882K.

  • Dowling & Yahnke's largest Q1 2020 buy was iShares MSCI ACWI ex US ETF: 23,419 shares worth $882K.
  • Dowling & Yahnke added most to Vanguard Morningstar Small-Cap ETF in Q1 2020, an estimated $5.86M increase.
  • Dowling & Yahnke's biggest Q1 2020 reduction was iShares MSCI EAFE Small-Cap ETF, cutting an estimated $4.54M.
  • Dowling & Yahnke fully exited DocuSign in Q1 2020, selling an estimated $977K.
  • Dowling & Yahnke's ten largest holdings make up 26% of its $1.04B portfolio in Q1 2020.
  • Dowling & Yahnke opened 14 new positions and closed 104 in Q1 2020.
  • Dowling & Yahnke's portfolio value fell 20% quarter-over-quarter to $1.04B.

Based on Dowling & Yahnke's 13F filing for Q1 2020, filed 15 May 2020.